Antimicrobial Resistance

Antimicrobial Resistance Indian Medical PG Question 1: A patient develops an infection of methicillin resistant Staphylococcus aureus. All of the following can be used to treat this infection except

• A. Cotrimoxazole
• B. Ciprofloxacin
• C. Cefaclor (Correct Answer)
• D. Vancomycin

Antimicrobial Resistance Explanation: ***Cefaclor*** - **Cefaclor** is a second-generation **cephalosporin**, which, like all beta-lactam antibiotics, is ineffective against **MRSA** because **MRSA** produces an altered penicillin-binding protein (PBP2a) encoded by the **mecA** gene. - This altered **PBP2a** has a low affinity for **beta-lactam antibiotics**, rendering them inactive. *Cotrimoxazole* - **Cotrimoxazole** (trimethoprim/sulfamethoxazole) is a commonly used and effective oral antibiotic for treating **MRSA** infections, particularly in outpatient settings. - It inhibits **folate synthesis** in bacteria, an essential pathway for their growth and replication. *Ciprofloxacin* - **Ciprofloxacin** is a **fluoroquinolone antibiotic** that can be used to treat certain **MRSA** infections, although resistance can be an issue. [2] - It works by inhibiting bacterial **DNA gyrase** and **topoisomerase IV**, crucial enzymes for DNA replication. [2] *Vancomycin* - **Vancomycin** is a **glycopeptide antibiotic** that is a first-line treatment for serious **MRSA** infections, especially in hospitalized patients. [1] - It works by inhibiting **bacterial cell wall synthesis** at a different site than beta-lactams, making it effective against **MRSA**. [1]

Antimicrobial Resistance Indian Medical PG Question 2: Which of the following is NOT a mechanism of antibiotic resistance?

• A. Efflux pump activity
• B. Inactivation by enzymes such as beta-lactamase
• C. Modification of drug target sites
• D. Increased drug absorption (Correct Answer)

Antimicrobial Resistance Explanation: ***Increased drug absorption*** - **Increased drug absorption** would lead to a higher intracellular concentration of the antibiotic, making it *more potent* against the bacteria rather than contributing to resistance. - Antibiotic resistance mechanisms aim to *reduce the effective concentration* of the drug at its target site or *alter the target itself*. *Efflux pump activity* - **Efflux pumps** are bacterial membrane proteins that actively pump antibiotics out of the bacterial cell [3]. - This mechanism *reduces the intracellular concentration* of the antibiotic, preventing it from reaching its therapeutic target [3]. *Inactivation by enzymes such as beta-lactamase* - Bacteria can produce enzymes like **beta-lactamase** that *chemically modify or degrade* the antibiotic molecule, rendering it inactive [2]. - This is a common mechanism of resistance against **beta-lactam antibiotics** (e.g., penicillin, cephalosporins) [2]. *Modification of drug target sites* - Bacteria can develop mutations that *alter the structure of the antibiotic's target site*, such as a bacterial ribosome or cell wall component [1]. - This change in the target means the antibiotic can no longer bind effectively or interfere with cellular processes, thus *losing its efficacy* [1].

Antimicrobial Resistance Indian Medical PG Question 3: Multi drug resistant tuberculosis is defined as resistance to?

• A. Rifampicin and Pyrazinamide
• B. INH and Rifampicin (Correct Answer)
• C. Resistance to all first line drugs
• D. INH and Pyrazinamide

Antimicrobial Resistance Explanation: ***INH and Rifampicin*** - **Multidrug-resistant tuberculosis (MDR-TB)** is specifically defined by resistance to at least **isoniazid (INH)** and **rifampicin** [1], which are the two most potent first-line anti-TB drugs. - This dual resistance makes treatment significantly more challenging and prolonged compared to drug-susceptible TB. *Rifampicin and Pyrazinamide* - While resistance to these drugs is serious, it does not specifically define MDR-TB unless resistance to **isoniazid** is also present. - **Pyrazinamide** is another first-line drug, but its resistance pattern alone with rifampicin does not meet the MDR-TB criteria. *Resistance to all first-line drugs* - Resistance to all four first-line drugs (isoniazid, rifampicin, pyrazinamide, and ethambutol) [1] is classified as **Extensively Drug-Resistant TB (XDR-TB)**, a more severe form of resistance than MDR-TB. - MDR-TB specifically refers to resistance to **INH and rifampicin**, not necessarily all first-line drugs. *INH and Pyrazinamide* - While resistance to both **isoniazid** and **pyrazinamide** is a concern, it does not meet the definition of MDR-TB. - The definition requires resistance to **rifampicin** in addition to isoniazid.

Antimicrobial Resistance Indian Medical PG Question 4: A diabetic patient developed cellulitis due to S. aureus, which was found to be methicillin resistant on the antibiotic sensitivity testing. All of the following antibiotics will be appropriate except ?

• A. Vancomycin
• B. Teicoplanin
• C. Linezolid
• D. Imipenem (Correct Answer)

Antimicrobial Resistance Explanation: ***Imipenem*** - **Imipenem** is a carbapenem antibiotic that is effective against many Gram-positive and Gram-negative bacteria, but it is **not active against MRSA (methicillin-resistant *Staphylococcus aureus*)**. - MRSA strains are resistant to all beta-lactam antibiotics, including penicillins, cephalosporins, and carbapenems like imipenem, due to the presence of the **mecA gene** which encodes for an altered penicillin-binding protein (PBP2a). *Vancomycin* - **Vancomycin** is a glycopeptide antibiotic that is a primary choice for treating **MRSA infections**, including cellulitis. - It inhibits cell wall synthesis by binding to the D-Ala-D-Ala precursor, preventing cross-linking, and is specifically active against **Gram-positive bacteria**. *Teicoplanin* - **Teicoplanin** is another glycopeptide antibiotic, similar to vancomycin, and is also considered a suitable agent for treating **MRSA infections**. - It works by inhibiting bacterial cell wall synthesis and has a **longer half-life** than vancomycin, allowing for less frequent dosing. *Linezolid* - **Linezolid** is an oxazolidinone antibiotic known for its activity against **Gram-positive bacteria**, including **MRSA** and vancomycin-resistant enterococci (VRE). - It inhibits protein synthesis by binding to the 50S ribosomal subunit, preventing the formation of the initiation complex.

Antimicrobial Resistance Indian Medical PG Question 5: All the following statements are true regarding beta-lactams except:

• A. Methicillin is not orally bioavailable and is given parenterally.
• B. Imipenem should be given with cilastatin
• C. Meropenem does not require cilastatin for protection against renal toxicity.
• D. Aztreonam shows cross-reactivity with cephalexin. (Correct Answer)

Antimicrobial Resistance Explanation: ***Aztreonam shows cross-reactivity with cephalexin.*** - **Aztreonam** is a monobactam with a distinct chemical structure from other beta-lactams, resulting in a different **allergy profile** and lack of significant **cross-reactivity** with other beta-lactams, including cephalosporins like cephalexin. - Its unique structure also means it is specifically active against **gram-negative bacteria** and generally resistant to common beta-lactamases that deactivate other beta-lactams. *Imipenem should be given with cilastatin* - **Imipenem** is rapidly metabolized in the renal tubules by **dehydropeptidase-1**, leading to reduced antibiotic concentrations and potential for nephrotoxicity. - **Cilastatin** is a dehydropeptidase inhibitor that prevents the breakdown of imipenem, ensuring adequate drug levels and reducing renal damage. *Methicillin is not orally bioavailable and is given parenterally.* - **Methicillin** is an acid-labile penicillin, meaning it is extensively degraded by stomach acid when taken orally, leading to poor absorption. - Due to its instability in acidic environments, methicillin must be administered **parenterally (intravenously or intramuscularly)** to achieve therapeutic concentrations. *Meropenem does not require cilastatin for protection against renal toxicity.* - **Meropenem** is another carbapenem, but it is much more stable to metabolism by **renal dehydropeptidase-1** compared to imipenem. - This inherent stability eliminates the need for co-administration with **cilastatin** to prevent its degradation and protect against nephrotoxicity.

Antimicrobial Resistance Flashcard 1 of 5

Question: _____ is the molecular basis of penicillin G resistance in pneumococci and meningococci.

Answer: Transformation

Antimicrobial Resistance Flashcard 2 of 5

Question: Tube and Agar dilution method are _____ methods to test antibiotic sensitivity.

Answer: dilution

Antimicrobial Resistance Flashcard 3 of 5

Question: KirbyBauer and Stokes method are _____ methods to test antibiotic sensitivity.

Answer: diffusion

Antimicrobial Resistance Flashcard 4 of 5

Question: When a subset of the total microbial population is resistant, despite the total microbial population being susceptible on testing, the phenomenon is called as?  _____

Answer: Heteroresistance

Antimicrobial Resistance Flashcard 5 of 5

Question: _____ genes are responsible for FQ resistance

Answer: gyrA and gyrB

Extra Information: